全文获取类型
收费全文 | 9481篇 |
免费 | 776篇 |
国内免费 | 233篇 |
专业分类
耳鼻咽喉 | 100篇 |
儿科学 | 179篇 |
妇产科学 | 391篇 |
基础医学 | 1212篇 |
口腔科学 | 200篇 |
临床医学 | 1038篇 |
内科学 | 1906篇 |
皮肤病学 | 146篇 |
神经病学 | 630篇 |
特种医学 | 305篇 |
外科学 | 1379篇 |
综合类 | 338篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 454篇 |
眼科学 | 191篇 |
药学 | 1029篇 |
4篇 | |
中国医学 | 194篇 |
肿瘤学 | 791篇 |
出版年
2023年 | 93篇 |
2022年 | 144篇 |
2021年 | 286篇 |
2020年 | 185篇 |
2019年 | 284篇 |
2018年 | 318篇 |
2017年 | 214篇 |
2016年 | 201篇 |
2015年 | 319篇 |
2014年 | 382篇 |
2013年 | 511篇 |
2012年 | 678篇 |
2011年 | 784篇 |
2010年 | 478篇 |
2009年 | 381篇 |
2008年 | 555篇 |
2007年 | 597篇 |
2006年 | 513篇 |
2005年 | 495篇 |
2004年 | 431篇 |
2003年 | 351篇 |
2002年 | 318篇 |
2001年 | 262篇 |
2000年 | 212篇 |
1999年 | 180篇 |
1998年 | 75篇 |
1997年 | 74篇 |
1996年 | 56篇 |
1995年 | 64篇 |
1994年 | 61篇 |
1993年 | 63篇 |
1992年 | 128篇 |
1991年 | 110篇 |
1990年 | 92篇 |
1989年 | 65篇 |
1988年 | 55篇 |
1987年 | 64篇 |
1986年 | 32篇 |
1985年 | 38篇 |
1984年 | 44篇 |
1983年 | 28篇 |
1982年 | 25篇 |
1981年 | 19篇 |
1980年 | 19篇 |
1979年 | 25篇 |
1978年 | 18篇 |
1976年 | 17篇 |
1975年 | 18篇 |
1973年 | 16篇 |
1972年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Yuh-Jyh Kuo MS Linda L. Shanbour PhD Dr. Thomas A. Miller MD 《Digestive diseases and sciences》1983,28(12):1121-1126
An isolated fundic mucosal preparation of dog stomach which is capable of exhibiting an alkaline secretion is described. A stable secretion was established 40 min to 1 hr after the mucosa was pretreated with the H2-antagonist cimetidine to block spontaneous acid output. Alkaline secretion decreased when Ca2+ was removed from the nutrient solution. This secretion was stimulated by dibutyryl cyclic GMP, but was not altered by acetylcholine, carbachol, or 16,16-dimethyl PGE2. Alkaline secretion from a similar antral mucosal preparation was stimulated by 16,16-dimethyl PGE2. We conclude that the 16,16-dimethyl PGE2-stimulated bicarbonate secretion previously demonstrated inin vivo canine fundic mucosa is not the result of a direct effect of PG on gastric mucosal cells and that an intact blood circulation or cholinergic innervation is required for this action to occur. 相似文献
993.
994.
Fernandes Priyanka Wang Karina Timmerman Jason Reyes Angela Holmes Faye Olaleye Omonike A. Salihu Hamisu M. Moerchen Victoria A. Belcher Harolyn M. E. Copeland-Linder Nikeea Noble Charlotte A. Vamos Cheryl A. Armstrong Anna Waters Catrina R. Long-White Deneen Brown Claudia Reddy Madhavi M. Kuo Alice 《Maternal and child health journal》2022,26(7):1415-1423
Maternal and Child Health Journal - The Maternal and Child Health (MCH) Pipeline Training Program, promotes development of a diverse health workforce by training undergraduate students from... 相似文献
995.
Tai Fai Fok Kuo Lam Chak K. Chan Pak Cheung Ng Hong Zhuang William Wong Kam Lau Cheung 《Pediatric pulmonology》1997,24(3):204-212
In a randomized double-blind cross-over study on 20 spontaneously breathing, oxygen-dependent preterm infants who had received positive pressure ventilation for respiratory distress syndrome, we tested the hypothesis that the one-way non-rebreathing valves of aerosol spacer devices might impair rather than enhance the delivery of aerosols to small infants by metered dose inhalers (MDI). Ten infants were given 2 doses (200 μg/dose) of MDI albuterol through a neonatal Aerochamber® 4 h apart. At random sequence, one dose was delivered with the non-rebreathing valve of the Aerochamber® in place; for the other dose, the valve had been removed. The experiment was repeated on another ten infants using a different spacer device (Babyhaler®) with or without its one-way inspiratory valve removed. During the first hour following aerosol administration, use of the non-valved spacers was associated with a significantly greater degree of tachycardia in both groups, and also lower transcutaneous carbon dioxide tension in the Aerochamber® group. All infants showed a reduction in respiratory system resistance and an improvement in functional residual capacity following albuterol treatment. In both groups, maximum reduction in respiratory system resistance, recorded 30 min after aerosol delivery, was significantly greater following the use of the non-valved spacers (Aerochamber®: 51.2 ± 3.1% vs. 35.0 ± 2.8%, P < 0.0001; Babyhaler®: 38.8 ± 2.3% vs. 19.2 ± 1.4%, P < 0.0001) than following the use of the spacers with a valve. The findings provide indirect evidence supporting our hypothesis and suggest that when the MDI is used to deliver therapeutic aerosols to non-ventilated newborns or small infants, a spacer device without a non-rebreathing valve should be used. Pediatr. Pulmonol. 1997; 24:204–212. © 1997 Wiley-Liss, Inc. 相似文献
996.
Lee JD Lee TH Kuo YW Huang YC Hsu HL Lin YH Wu CY Huang YC Lee M Hsiao KM 《Current neurovascular research》2012,9(3):200-206
The low-density lipoprotein receptor (LDLR) gene has been reported to be associated with cerebral infarction. This study aimed to explore 2 genetic LDLR variants, rs688 and rs5925, for their potential roles in cerebral infarction. This genetic association study was conducted within an isolated Taiwanese population; 815 ischemic stroke patients (431 with atherothrombotic stroke and 384 with lacunar infarction) and 430 normal controls were enrolled. There was no significant difference in the genetic frequency of rs688 and rs5925 between the control group and overall ischemic stroke, atherothrombotic stroke, or lacunar infarct groups. However, when analyzing the association between the haplotypes related to rs688 and rs5925 and cerebral ischemic stroke, the most common haplotype allele CT was used as the reference allele, and the haplotype TC associated with a 65% increased risk of overall ischemic stroke, 72% increased risk of atherothrombotic stroke, and 70% increased risk of lacunar infarction; this indicated a synergistic effect between these 2 single-nucleotide polymorphisms. The LDLR analysis based on the haplotypes rs688 and rs5925 was conducted in a Taiwanese population and provided preliminary evidence suggesting that genetic polymorphisms of LDLR are associated with cerebral infarction. 相似文献
997.
Gait parameters such as stride length, width, and period, as well as their respective variabilities, are widely used as indicators of mobility and walking function. Foot placement and its variability have thus been applied in areas such as aging, fall risk, spinal cord injury, diabetic neuropathy, and neurological conditions. But a drawback is that these measures are presently best obtained with specialized laboratory equipment such as motion capture systems and instrumented walkways, which may not be available in many clinics and certainly not during daily activities. One alternative is to fix inertial measurement units (IMUs) to the feet or body to gather motion data. However, few existing methods measure foot placement directly, due to drift associated with inertial data. We developed a method to measure stride-to-stride foot placement in unconstrained environments, and tested whether it can accurately quantify gait parameters over long walking distances. The method uses ground contact conditions to correct for drift, and state estimation algorithms to improve estimation of angular orientation. We tested the method with healthy adults walking over-ground, averaging 93 steps per trial, using a mobile motion capture system to provide reference data. We found IMU estimates of mean stride length and duration within 1% of motion capture, and standard deviations of length and width within 4% of motion capture. Step width cannot be directly estimated by IMUs, although lateral stride variability can. Inertial sensors measure walks over arbitrary distances, yielding estimates with good statistical confidence. Gait can thus be measured in a variety of environments, and even applied to long-term monitoring of everyday walking. 相似文献
998.
Hsiang Yang Han‐Yi Chou Chun‐Pin Chiang Mark Yen‐Ping Kuo 《Journal of oral pathology & medicine》2011,40(6):483-489
J Oral Pathol Med (2010) 40 : 483–489 Background: 5‐aminolevulinic acid‐based photodynamic therapy (5‐ALA‐PDT) is being used to treat oral pre‐cancerous and cancerous lesions with some encouraging clinical outcomes. However, the exact mechanisms behind the photodynamic treatment are still not fully elucidated. Method: Flow cytometry, TdT‐mediated dUTP nick end labeling assay and Western blot analysis were used to investigate the effects of 5‐ALA‐PDT on human oral cancer Ca9–22 cells. Results: We found that 5‐ALA‐PDT induces apoptosis in Ca9–22 cells. Western blotting showed that 5‐ALA‐PDT activates both the caspase‐8 and caspase‐9 pathways, which differed from previous studies conducted in other cell types. Activation of JNK was evident as early as 30 min. The caspases activation was inhibited by JNK inhibitor SP600125. Treatment with NF‐κB inhibitor Bay 11‐7082 (Bay) completely abrogated ALA‐PDT‐induced JNK activation. In addition, Bay and SP600125 almost completely abolished ALA‐PDT‐induced apoptosis. Conclusion: These results demonstrate significant involvement of caspase‐8 and ‐9 and their upstream NF‐κB‐JNK pathways in ALA‐PDT‐induced apoptosis. Future studies on how NF‐κB and JNK activity regulate ALA‐PDT response should provide a better strategy for the treatment of oral cancer. 相似文献
999.
1000.
S.-C. Kuo C.-C. Lin A. Elsarawy Y.-H. Lin S.-H. Wang Y.-J. Wu C.-L. Chen 《Transplantation proceedings》2017,49(8):1870-1874